178 related articles for article (PubMed ID: 34232334)
1. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis.
Velonakis G; Papadopoulos VE; Karavasilis E; Filippiadis DK; Zouvelou V
Neuroradiology; 2021 Sep; 63(9):1531-1538. PubMed ID: 34232334
[TBL] [Abstract][Full Text] [Related]
2. Eye muscle antibodies in patients with ocular myasthenia gravis: possible mechanism for eye muscle inflammation in acetylcholine-receptor antibody-negative patients.
Gunji K; Skolnick C; Bednarczuk T; Benes S; Ackrell BA; Cochran B; Kennerdell JS; Wall JR
Clin Immunol Immunopathol; 1998 Jun; 87(3):276-81. PubMed ID: 9646837
[TBL] [Abstract][Full Text] [Related]
3. Eye Muscle MRI in Myasthenia Gravis and Other Neuromuscular Disorders.
Keene KR; Notting IC; Verschuuren JJGM; Voermans N; de Keizer ROB; Beenakker JM; Tannemaat MR; Kan HE
J Neuromuscul Dis; 2023; 10(5):869-883. PubMed ID: 37182896
[TBL] [Abstract][Full Text] [Related]
4. Ocular myasthenia gravis: predictive value of single-fiber electromyography.
Weinberg DH; Rizzo JF; Hayes MT; Kneeland MD; Kelly JJ
Muscle Nerve; 1999 Sep; 22(9):1222-7. PubMed ID: 10454717
[TBL] [Abstract][Full Text] [Related]
5. Response to treatment in pediatric ocular myasthenia gravis.
Xu L; Castro D; Reisch JS; Iannaccone ST
Muscle Nerve; 2020 Feb; 61(2):226-230. PubMed ID: 31650555
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the differential susceptibility of extraocular muscles in patients diagnosed with ocular myasthenia gravis based on the computerized diplopia test and the Ocular Motor Nerve Palsy Scale.
Fan YF; Tu SJ; Liu Y; Li XM; Liu TJ; Zhou LY
Front Neurol; 2024; 15():1353248. PubMed ID: 38872815
[TBL] [Abstract][Full Text] [Related]
7. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
8. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study.
Hendricks TM; Bhatti MT; Hodge DO; Chen JJ
Am J Ophthalmol; 2019 Sep; 205():99-105. PubMed ID: 31077669
[TBL] [Abstract][Full Text] [Related]
10. The pattern of extra-ocular muscle involvement in ocular myasthenia.
Cleary M; Williams GJ; Metcalfe RA
Strabismus; 2008; 16(1):11-8. PubMed ID: 18306117
[TBL] [Abstract][Full Text] [Related]
11. Orbital magnetic resonance imaging of extraocular muscles in chronic progressive external ophthalmoplegia: specific diagnostic findings.
Ortube MC; Bhola R; Demer JL
J AAPOS; 2006 Oct; 10(5):414-8. PubMed ID: 17070475
[TBL] [Abstract][Full Text] [Related]
12. T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis.
Wang ZY; Okita DK; Howard J; Conti-Fine BM
Neurology; 1998 Apr; 50(4):1045-54. PubMed ID: 9566393
[TBL] [Abstract][Full Text] [Related]
13. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
MacLennan C; Beeson D; Buijs AM; Vincent A; Newsom-Davis J
Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
[TBL] [Abstract][Full Text] [Related]
14. The feasibility of quantitative MRI of extra-ocular muscles in myasthenia gravis and Graves' orbitopathy.
Keene KR; van Vught L; van de Velde NM; Ciggaar IA; Notting IC; Genders SW; Verschuuren JJGM; Tannemaat MR; Kan HE; Beenakker JM
NMR Biomed; 2021 Jan; 34(1):e4407. PubMed ID: 32893386
[TBL] [Abstract][Full Text] [Related]
15. Single-fiber Electromyography in the Extensor Digitorum Communis for the Predictive Prognosis of Ocular Myasthenia Gravis: A Retrospective Study of 102 Cases.
Guan YZ; Cui LY; Liu MS; Niu JW
Chin Med J (Engl); 2015 Oct; 128(20):2783-6. PubMed ID: 26481746
[TBL] [Abstract][Full Text] [Related]
16. Ocular myasthenia gravis.
Vaphiades MS; Bhatti MT; Lesser RL
Curr Opin Ophthalmol; 2012 Nov; 23(6):537-42. PubMed ID: 23047171
[TBL] [Abstract][Full Text] [Related]
17. Risk for generalization in ocular onset myasthenia gravis: experience from a neuro-ophthalmology clinic.
Kısabay A; Özdemir HN; Gökçay F; Çelebisoy N
Acta Neurol Belg; 2022 Apr; 122(2):337-344. PubMed ID: 33544334
[TBL] [Abstract][Full Text] [Related]
18. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
Kupersmith MJ
J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic study of extraocular muscles in thyroid-associated ophthalmopathy coexisting with ocular myasthenia gravis: a case report.
Ma R; Cheng Y; Gan L; Zhou X; Qian J
BMC Ophthalmol; 2020 Apr; 20(1):166. PubMed ID: 32321476
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Ocular Myasthenia Gravis in an Argentinian Population.
Aguirre F; Villa AM
Eur Neurol; 2018; 79(3-4):113-117. PubMed ID: 29428956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
